Thanks to a new technology, the diagnosis of brain cancer undergoes a breakthrough. The credit goes to cancer diagnostics company and University of Strathclyde Dxcover spin-out company. The company has indeed launched the liquid biopsy Dxcover, which was also effective in the early days of cancer growth, at a smaller volume and earlier stage.
q
There Research was published in the scientific journal Cancers.
Brain cancer: here are the advantages of the Dxcover liquid biopsy
According to Cancer Research UK, a 12,000 people in Britain are diagnosed with brain cancer each year and survival rates are 12% five years after diagnosis.
Read Also
- Mercedes and Red Bull: sustainable development | FormulaPassion.it Jul 1, 2021
- Where consumers got pandemic relief, complaints to CFPB fell Jul 2, 2021
- Barbara d’Urso furious at Afternoon 5: what happened? Sep 25, 2021
- Verstappen: “Nice fight with Lewis” | FormulaPassion.it Jul 17, 2021
- Twitter, over $ 800 million agreement to close class action Sep 20, 2021
- Arturo Peniche’s daughter faints during high altitude competition in “I’m Famous, get me out of here!” May 26, 2022
- USA: Live cat found in suitcase at JFK airport in New York Nov 23, 2022